These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 6698659

  • 1. Mepindolol sulfate in the hyperkinetic heart syndrome.
    Bonelli J.
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):42-4. PubMed ID: 6698659
    [Abstract] [Full Text] [Related]

  • 2. [Exertion insufficiency during beta blocker therapy in the hyperkinetic heart syndrome].
    Niehues B, Hermanns L, Kortenbruck R, Behrenbeck DW, Hilger HH.
    Verh Dtsch Ges Inn Med; 1978 Jan; (84):736-9. PubMed ID: 742112
    [No Abstract] [Full Text] [Related]

  • 3. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
    Masoni A, Galassi A, Ginevrino P, Libretti A, Morgagni W, Rappelli A, Tomasi AM.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
    [Abstract] [Full Text] [Related]

  • 4. [Hemodynamic differences in the effects of mepindolol-sulfate and propranolol after 4 weeks treatment under conditions of rest and physical exercise in patients with coronary heart disease (author's transl)].
    Bonelli J, Magometschnigg D, Hitzenberger G, Kaik G.
    Z Kardiol; 1978 Jan; 67(1):46-50. PubMed ID: 629073
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hemodynamics in patients with coronary heart disease under conditions of physical exercise before and after mepindolol-sulfate (author's transl)].
    Bonelli J, Magometschnigg D, Hitzenberger G, Kaik G.
    Z Kardiol; 1978 Jan; 67(1):51-6. PubMed ID: 343414
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Further indications for Visken.
    Holmes D, Schutz W.
    Indian Heart J; 1972 Jun; 24():Suppl 1:244-8. PubMed ID: 4667018
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of hyperkinetic heart syndrome with alinidine and propranolol].
    Schräder R, Degoutrie G, Landgraf H, Kaltenbach M.
    Klin Wochenschr; 1987 Jan 15; 65(2):69-75. PubMed ID: 3560788
    [Abstract] [Full Text] [Related]

  • 13. Elevated plasma catecholamines in young hypertensive and hyperkinetic patients: effect of pindolol.
    Dominiak P, Grobecker H.
    Br J Clin Pharmacol; 1982 Jan 15; 13(Suppl 2):381S-390S. PubMed ID: 7104155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluating mepindolol in a test model of examination anxiety in students.
    Krope P, Kohrs A, Ott H, Wagner W, Fichte K.
    Pharmacopsychiatria; 1982 Mar 15; 15(2):41-7. PubMed ID: 6123122
    [Abstract] [Full Text] [Related]

  • 16. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE, Kanoupakis EM, Kalebubas MD, Igoumenidis NE, Vardakis KE, Mavrakis HE, Vardas PE.
    Europace; 2001 Jan 15; 3(1):73-9. PubMed ID: 11271956
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.